StratGraph
Companies / Materials
FCX

Freeport-McMoRan

Copper

CopperAnalysis in progress
In progress

We are decoding this company's strategy and relationships

New analyses are published every weekday. Founding members get them first.

Business at a glance

Operating-health scores describe reported fundamentals on a 0–100 scale. They are not a rating of the stock. How they work

Operating health56
Growth30
Profitability65
Cash generation19
Balance sheet88
Dilution control79
Key ratios and five-year financials
Latest quarter revenue YoY (2026-09-30)8.9%Revenue growth (FY)0.1%Revenue CAGR (3y)2.7%Gross margin26.1%Operating margin25.9%Net margin16.5%Free cash flow margin4.4%R&D / revenue—Stock comp / revenue0.5%Net debt / operating cash flow1.07xCurrent ratio2.29Diluted share count change-0.1%
Fiscal year endingFY 2021-12FY 2022-12FY 2023-12FY 2024-12FY 2025-12
Revenue$22.4B$23.3B$22.7B$25.2B$25.2B
Gross profit$8.4B$8.2B$7.0B$7.4B$6.6B
Operating income$8.4B$7.0B$6.2B$6.9B$6.5B
Net income$5.4B$4.5B$3.8B$4.4B$4.2B
Operating cash flow$7.7B$5.1B$5.3B$7.2B$5.6B
Capital expenditure$2.1B$3.5B$4.8B$4.8B$4.5B
Free cash flow$5.6B$1.7B$455M$2.4B$1.1B
Stock-based comp$98M$95M$109M$109M$121M
Buybacks$488M$1.3B$0$59M$107M
Dividends$331M$866M$863M$865M$865M
Cash$8.1B$8.1B$4.8B$3.9B$3.8B
Total debt$9.8B$11.7B$10.2B$9.0B$9.8B
Equity$14.0B$15.6B$16.7B$17.6B$18.9B

StratGraph publishes general, impersonal research about public companies based on public filings. It is not investment advice, not a recommendation to buy, sell or hold any security, and not tailored to any reader's circumstances. Content may contain errors and may be partly generated with AI tools; verify against the original filings, which are linked. Authors may not trade securities discussed within the window set by our trading policy. Full disclaimer.